Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T G Kwiatkowski

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Trauma|November 1, 1986
New York State mandatory seatbelt use law: patterns of seatbelt use before and after legislationB W Pace, R Thailer, T G Kwiatkowski
Cerebrovascular Diseases (Basel, Switzerland)|June 1, 2001
Differences between anterior and posterior circulation stroke in TOASTR B Libman, T G Kwiatkowski, M D Hansen, et al.
Neurology|September 11, 2002
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke TrialA Bruno, S R Levine, M R Frankel, et al.
The New England Journal of Medicine|June 11, 1999
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study GroupT G Kwiatkowski, R B Libman, M Frankel, et al.
Neurology|May 5, 1998
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study GroupS C Fagan, L B Morgenstern, A Petitta, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Trauma|November 1, 1986
New York State mandatory seatbelt use law: patterns of seatbelt use before and after legislationB W Pace, R Thailer, T G Kwiatkowski
Cerebrovascular Diseases (Basel, Switzerland)|June 1, 2001
Differences between anterior and posterior circulation stroke in TOASTR B Libman, T G Kwiatkowski, M D Hansen, et al.
Neurology|September 11, 2002
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke TrialA Bruno, S R Levine, M R Frankel, et al.
The New England Journal of Medicine|June 11, 1999
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study GroupT G Kwiatkowski, R B Libman, M Frankel, et al.
Neurology|May 5, 1998
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study GroupS C Fagan, L B Morgenstern, A Petitta, et al.
Pageof 1